Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Sun Pharmaceutical Industries Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	524715
ISIN Demat	INE044A01036
Book Value	101.44

NSE Code	SUNPHARMA
Dividend Yield %	0.93
Market Cap	4145331.03

P/E	96.79
EPS	17.85
Face Value	1


	BSE		NSE

15-Jul-2025

Last Price	1727.70
Net Change	45.65
% Change	2.71%
Prev.Close	1682.05
Open	1700.00
High	1730.95
Low	1688.85
Volume	151273

Last Price	1727.50
Net Change	44.9
% Change	2.67%
Prev.Close	1682.60
Open	1705.00
High	1730.90
Low	1687.90
Volume	3332578

Value	258601610
Best Buy	0.00
Best Sell	0.00
Best Quantity	0
Sell Quantity	0
Today's Range	1730.95
52-Week High	1960.20
52-Week Low	1555.00

Value	5713624478.1
Best Buy	1727.50
Best Sell	0.00
Best Quantity	26
Sell Quantity	0
Today's Range	1730.90
52-Week High	1960.35
52-Week Low	1553.05

Open Price	1698.00
High Price	1733.90
Low Price	1690.20
Last Price	1730.90
Prev Close	1688.10
Change	42.80
% Change	2.54 %

Average Price	1718.08
Underlying Value	1727.50
Number of contracts traded	15449
Turnover in Rs. Lakhs	92899
Open Interest	18558050.00
Change in O I	534800.00
% Change in O I	2.97 %

Today

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	26
Price	1727.50

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	350
Price	1731.1

Quantity	1400
Price	1731.9

Holding Details

Latest Corporate Events

Bonus

1 : 1

29-Jul-13

Book Closure

25-Aug-21

31-Aug-21

Dividend

550 %

07-Jul-25

Company News

15-07-2025

Sun Pharmaceutical Indust...

15-07-2025

Sun Pharmaceutical Indust...

14-07-2025

Sun Pharma Advanced Resea...

25-06-2025

Sun Pharmaceutical Indus...

25-06-2025

Sun Pharma’s partner with...

25-06-2025

Sun Pharma gains on the B...

14-06-2025

USFDA conducts GMP inspec...

Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.